Filing Details

Accession Number:
0001062993-23-023239
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-28 16:31:17
Reporting Period:
2023-12-26
Accepted Time:
2023-12-28 16:31:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1205922 Vaccinex Inc. VCNX Pharmaceutical Preparations (2834) 161603202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1748247 Van Strydonck, Gerald E. C/O Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester NY 14620
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-26 3,149 $0.72 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $204.00 2027-09-15 426 426 Direct
Common Stock Stock Option (Right to Buy) $78.90 2029-03-30 166 166 Direct
Common Stock Stock Option (Right to Buy) $116.70 2020-05-15 514 514 Direct
Common Stock Stock Option (Right to Buy) $82.80 2029-06-29 159 159 Direct
Common Stock Stock Option (Right to Buy) $107.55 2029-09-27 123 123 Direct
Common Stock Stock Option (Right to Buy) $72.75 2029-12-28 182 182 Direct
Common Stock Stock Option (Right to Buy) $59.25 2021-05-14 1,045 1,045 Direct
Common Stock Stock Option (Right to Buy) $32.25 2022-05-11 1,905 1,905 Direct
Common Stock Stock Option (Right to Buy) $16.80 2023-05-12 3,550 3,550 Direct
Common Stock Stock Option (Right to Buy) $6.15 2024-05-11 9,589 9,589 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-09-15 426 426 Direct
2029-03-30 166 166 Direct
514 514 Direct
2029-06-29 159 159 Direct
2029-09-27 123 123 Direct
2029-12-28 182 182 Direct
1,045 1,045 Direct
1,905 1,905 Direct
3,550 3,550 Direct
9,589 9,589 Direct
Footnotes
  1. Exercisable in full as of the date of this report.
  2. This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  3. This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  4. This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
  5. This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
  6. This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.